Opti9 Technologies announced that it has achieved Amazon Web Services (AWS) Premier tier in the AWS Partner Network (APN).

Read the latest Microsoft news from Engadget's news desk on Xbox, Copilot AI, Azure, Windows, the Office suite of software and more.

Microsoft has canceled its $1 billion data centers project in Ohio, citing it as an investment strategy. Experts warn that President Trump’s tariffs could be devastating for the American tech industry ...

Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet.

(AP Photo/Jason Redmond) Microsoft said it is “slowing or pausing” some of its data center construction, including a $1 billion project in Ohio, the latest sign that the demand for artificial ...

The EU said Wednesday it is considering streamlining artificial intelligence and data rules as part of a broader push to help European businesses keep up with US and Chinese rivals. The European Union ...

Microsoft has cancelled its $1 billion data centre project in Ohio, citing rising costs due to tariffs imposed by the Trump administration. Initially set to create thousands of jobs and boost the ...

Microsoft is reportedly working on a redesigned Windows 11 Start menu that can be customised more easily. A report by The Verge has revealed that the new Start menu has a bigger layout and is ...

Developers and architects urge Maharashtra DCM Eknath Shinde, who also serves as the housing minister, to restore online access to property data of Mumbai CREDAI-MCHI, an apex body of real estate ...

Microsoft says it's “slowing or pausing” some of data center construction, including a $1 billion project in Ohio Microsoft said it is “slowing or pausing” some of its data center ...

Microsoft has paused plans for a $1 billion data center project in central Ohio. The tech giant shared with the Columbus Dispatch that it is not moving forward with three planned data centers in ...

These results show the intravenous monoclonal ... investigator Richard J. Nowak, MD, MS, explains inebilizumab’s mechanism of action and how the 52-week data build on 26-week patient-reported ...